Market Place
Sourcing Support
Kriya Publishes Preclinical Data on AAV-FGF21 Gene Therapy
13 Nov 2024 //
GLOBENEWSWIRE
Kriya Presents KRIYA-586 Preclinical Data For Thyroid Eye Disease
12 Sep 2024 //
GLOBENEWSWIRE
Kriya Appoints Scientific Co-Founder J. Fraser as Chief Gene Therapy Officer
08 Jul 2024 //
GLOBENEWSWIRE
Kriya Appoints Katherine Eade As Chief Legal Officer
18 Jun 2024 //
GLOBENEWSWIRE
Kriya: 3 Presentations At ARVO 2024 Annual Meeting
02 May 2024 //
GLOBENEWSWIRE
Kriya Announces 6 Presentations At ASGCT 2024
22 Apr 2024 //
GLOBENEWSWIRE
Kriya Provides Update on Pipeline Progress
08 Jan 2024 //
GLOBENEWSWIRE
Kriya Announces Gene Therapy Program for Thyroid Eye Disease
05 Jan 2024 //
GLOBENEWSWIRE
Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference
20 Dec 2023 //
GLOBENEWSWIRE
Everads Enters Agreement with Kriya for Development of Ocular Gene Therapy
27 Sep 2023 //
PR NEWSWIRE
Kriya Announces Exclusive License and Collaboration Agreement with Everads
27 Sep 2023 //
GLOBENEWSWIRE
Kriya Acquires Tramontane Therapeutics & Launches Gene Therapy Program for NASH
06 Sep 2023 //
GLOBENEWSWIRE
Kriya Announces $150 Million Addition to its Series C
26 Jul 2023 //
GLOBENEWSWIRE
Kriya to Present 10 Abstracts at the 2023 ASGCT Annual Meeting
02 May 2023 //
BUSINESSWIRE
Kriya buys Redpin to chart gene therapy course in neurology
17 Nov 2022 //
FIERCEBIOTECH
Kriya Appoints Curt Herberts as President and Chief Operating Officer
25 Aug 2022 //
BUSINESSWIRE
Kriya banks $270M series C to be one-stop shop in gene therapy
16 May 2022 //
FIERCEBIOTECH
Twist`s antibodies to wind up with Kriya`s AAV gene therapies
10 Mar 2022 //
FIERCEBIOTECH
Kriya Appoints Ma’an Muhsin, as President & CMOr of Oncology Division
03 Feb 2022 //
BUSINESSWIRE
Kriya Licenses Next Generation Complement-Targeted Gene Therapies
26 Jan 2022 //
BUSINESSWIRE
Kriya Expands Gene Therapy Pipeline, Establishes Rare Disease Therapeutic Area
07 Jan 2022 //
BUSINESSWIRE
Kriya Appoints Theresa Heah as CMO and President of Kriya Ophthalmology
14 Oct 2021 //
BUSINESSWIRE
Kriya Completes Renovation of Facility for Scalable Gene Therapy Manufacturing
29 Jul 2021 //
BUSINESSWIRE
Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering
15 Jul 2021 //
PHARMACEUTICAL TECHNOLOGHY
Kriya grabs $100M to bankroll gene therapies for common diseases
14 Jul 2021 //
FIERCEBIOTECH
Kriya Therapeutics Completes $100 Million Series B Financing
14 Jul 2021 //
BUSINESS WIRE
Kriya Therapeutics Completes $100 Million Series B Financing
14 Jul 2021 //
BUSINESS WIRE
